203. Switzerland was pleased to participate in the 2022 Workshop on the Implementation of Article 66.2 of the TRIPS Agreement. We were asked to focus our presentation on a specific thematic area. We have chosen to focus on health technologies as Switzerland is a leader in this field and aims to improve access to proven and newly developed, safe, effective, high-quality, affordable and financially sustainable medicines.
204. The Workshop format was a good opportunity to present a brief update of the 2021 report which was circulated in September 2021 and in particular, to present three selected Geneva-based Product Development partnerships (PDPs) – FIND, MMV and DNDi - to foster local production and greater access to medical technologies. We would like to thank the Secretariat for the organization of the Workshop. The constructive discussions held throughout the Workshop will certainly contribute to the continued collaboration on technology transfer. We greatly appreciated the summary provided by the Secretariat that lists all incentives and projects implemented by the reporting Members. Additionally, specific summaries for each field of technology transfer were presented just before each thematic session. This is very helpful to keep the overview of donors, projects, and beneficiaries in the specific field of technology and knowledge transfer. We suggest maintaining this good practice.
205. Switzerland remains committed to engage in the TRIPS Council's discussion on the implementation of Article 66.2 and to promote and encourage technology transfer to LDCs.